INTROGEN THERAPEUTICS INC
S-1/A, EX-27.1, 2000-08-02
PHARMACEUTICAL PREPARATIONS
Previous: INTROGEN THERAPEUTICS INC, S-1/A, EX-23.1, 2000-08-02
Next: AMAZON COM INC, 10-Q, 2000-08-02



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) AUDITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED 6/30/00.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                           1,789
<SECURITIES>                                     9,976
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                      1,734
<CURRENT-ASSETS>                                13,504
<PP&E>                                          13,141
<DEPRECIATION>                                   2,988
<TOTAL-ASSETS>                                  24,855
<CURRENT-LIABILITIES>                            3,241
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         4,134
<OTHER-SE>                                      13,582
<TOTAL-LIABILITY-AND-EQUITY>                    24,855
<SALES>                                          2,184
<TOTAL-REVENUES>                                 8,388
<CGS>                                            1,476
<TOTAL-COSTS>                                    1,476
<OTHER-EXPENSES>                                14,776
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (582)
<INCOME-PRETAX>                                (7,724)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (7,724)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,724)
<EPS-BASIC>                                     (1.89)
<EPS-DILUTED>                                   (0.47)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission